Democrats dial back drug-pricing plans to win over moderates

By Politico
| September 30, 2021

It's a sign the drug industry is bending a potential compromise in manufacturers' favor after spending more than $171 million lobbying in the first half of this year.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...